E-viri
PDF
Recenzirano
Odprti dostop
-
Patel, Vivek L; Busch, Evan L; Friebel, Tara M; Leslie, Goska; McGuffog, Lesley; Agnarsson, Bjarni A; Ahmed, Munaza; Azzollini, Jacopo; Barkardottir, Rosa B; Barnes, Daniel R; Barroso, Alicia; Belotti, Muriel; Bertelsen, Birgitte; Bonanni, Bernardo; Brunet, Joan; Caldés, Trinidad; Campbell, Ian G; Carnevali, Ileana; Chan, Tsun L; Collaborators, Embrace; Cook, Jackie; Damante, Giuseppe; Dennis, Joe; Domchek, Susan M; Donaldson, Alan; Ejlertsen, Bent; Engel, Christoph; Faivre, Laurence; Faust, Ulrike; Feliubadaló, Lídia; Gauthier-Villars, Marion; Géczi, Lajos; Gesta, Paul; Giannini, Giuseppe; Glendon, Gord; Godwin, Andrew K; Gutierrez-Barrera, Angelica M; Hamann, Ute; Honisch, Ellen; Izatt, Louise; Jager, Agnes; Johannsson, Oskar Th; Joseph, Vijai; Kang, Eunyoung; Kiiski, Johanna I; Kim, Sung-Won; Ko, Kwang-Pil; Kramer, Gero; Krogh, Lotte; Kwong, Ava; Larsen, Mirjam; Lasset, Christine; Lazaro, Conxi; Lemke, Johannes; Lesueur, Fabienne; Llovet, Patricia; Lopez-Fernández, Adria; Matricardi, Laura; Mebirouk, Noura; Montagna, Marco; Moserle, Lidia; Navratilova, Marie; Olah, Edith; Ong, Kai-Ren; Osorio, Ana; Ott, Claus-Eric; Petersen, Annabeth Høgh; Porteous, Mary E; Radice, Paolo; Rantala, Johanna; Rookus, Matti A; Rossing, Caroline M; Saule, Claire; Scarpitta, Rosa; Shah, Payal D; Skytte, Anne-Bine; Snape, Katie; Solano, Angela R; Soucy, Penny; Southey, Melissa C; Spurdle, Amanda B; Steele, Linda; Tan, Yen Y; Teo, Soo Hwang; Tischkowitz, Marc; Toland, Amanda E; Torres, Diana; Toss, Angela; van der Baan, Frederieke H; van Hest, Liselotte P; Viel, Alessandra; Villa, Roberta; von Wachenfeldt, Anna; Wang-Gohrke, Shan; Wappenschmidt, Barbara; Yadav, Siddhartha; Yannoukakos, Drakoulis; Zorn, Kristin K; Pomerantz, Mark M; Nielsen, Henriette Roed
Cancer research (Chicago, Ill.), 02/2020, Letnik: 80, Številka: 3Journal Article
Pathogenic sequence variants (PSV) in or ( ) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 and 171 male PSV carriers with prostate cancer, and 3,388 and 2,880 male PSV carriers without prostate cancer. PSVs in the 3' region of (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 HR = 1.78; 95% confidence interval (CI), 1.25-2.52; = 0.001, as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; = 0.0002). No genotype-phenotype associations were detected for PSVs in . These results demonstrate that specific PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
